| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C Quin. Nursing evaluation of the use of clozapine: an interim progress report. The Australian and New Zealand journal of mental health nursing. vol 4. issue 1. 1997-04-10. PMID:9086954. |
clozapine, an atypical neuroleptic, has demonstrated some success in the treatment of schizophrenia in clients regarded as treatment resistive. |
1997-04-10 |
2023-08-12 |
Not clear |
| T R Barnes, C J McEvedy, H E Nelso. Management of treatment resistant schizophrenia unresponsive to clozapine. The British journal of psychiatry. Supplement. issue 31. 1997-03-28. PMID:8968653. |
management of treatment resistant schizophrenia unresponsive to clozapine. |
1997-03-28 |
2023-08-12 |
Not clear |
| I A Treves, M Y Neufel. EEG abnormalities in clozapine-treated schizophrenic patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 6. issue 2. 1997-03-21. PMID:8791033. |
a prospective study of eeg findings and occurrence of seizures in patients with refractory schizophrenia treated with clozapine has been conducted. |
1997-03-21 |
2023-08-12 |
Not clear |
| T M Shiovitz, T L Welke, P D Tigel, R Anand, R D Hartman, J J Sramek, N M Kurtz, N R Cutle. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophrenia bulletin. vol 22. issue 4. 1997-03-19. PMID:8938913. |
following the conduct of a 28-day inpatient bioequivalence study of clozapine in schizophrenia patients, withdrawal effects after abrupt discontinuation from clozapine were assessed. |
1997-03-19 |
2023-08-12 |
Not clear |
| I Weiner, E Shadach, R Tarrasch, R Kidron, J Feldo. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biological psychiatry. vol 40. issue 9. 1997-03-18. PMID:8896769. |
the latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. |
1997-03-18 |
2023-08-12 |
rat |
| M Rietschel, D Naber, H Oberländer, R Holzbach, R Fimmers, K Eggermann, H J Möller, P Propping, M M Nöthe. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 15. issue 5. 1997-03-14. PMID:8914122. |
to test the hypothesis that inter-individual differences in response to clozapine and the occurrence of side-effects might be influenced by variations in the dopamine d4 receptor gene, we examined frequencies of four known polymorphic sites affecting protein structure in the dopamine d4 receptor gene in 149 patients with schizophrenia or schizoaffective disorder treated with clozapine. |
1997-03-14 |
2023-08-12 |
Not clear |
| B A Ellenbroek, L J Lubbers, A R Cool. Activity of "seroquel" (ICI 204,636) in animal models for atypical properties of antipsychotics: a comparison with clozapine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 15. issue 4. 1997-03-06. PMID:8887995. |
likewise, ici 204,636 and clozapine were found to prevent the amphetamine-induced social isolation in monkeys, suggesting a good therapeutic effect mitigating the negative symptoms in schizophrenia. |
1997-03-06 |
2023-08-12 |
rat |
| F Raleig. Use of novel antipsychotic drugs. Pharmacotherapy. vol 16. issue 6 Pt 2. 1997-03-04. PMID:8948000. |
the atypical antipsychotic agents clozapine and risperidone bring new insight into the care and treatment of patients with schizophrenia. |
1997-03-04 |
2023-08-12 |
Not clear |
| V Sharm. Re: clozapine--current status and role in the pharmacotherapy of schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 41. issue 7. 1997-01-29. PMID:8884040. |
re: clozapine--current status and role in the pharmacotherapy of schizophrenia. |
1997-01-29 |
2023-08-12 |
Not clear |
| Y al-Semaa. Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 41. issue 7. 1997-01-29. PMID:8884041. |
bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia. |
1997-01-29 |
2023-08-12 |
Not clear |
| H Y Meltzer, M A Lee, R Ranjan, E A Mason, P A Col. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine. Psychopharmacology. vol 124. issue 1-2. 1997-01-29. PMID:8935814. |
the objective of this study was to report the effect of the slow withdrawal of clozapine from 19 patients with neuroleptic-responsive schizophrenia at the end of a 2-year clinical trial of clozapine and to compare this with the results of naturalistic discontinuation of clozapine treatment in 64 neuroleptic-resistant schizophrenic patients. |
1997-01-29 |
2023-08-12 |
Not clear |
| S Kumra, J A Frazier, L K Jacobsen, K McKenna, C T Gordon, M C Lenane, S D Hamburger, A K Smith, K E Albus, J Alaghband-Rad, J L Rapopor. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Archives of general psychiatry. vol 53. issue 12. 1997-01-10. PMID:8956674. |
in this study, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia. |
1997-01-10 |
2023-08-12 |
Not clear |
| C VanderZwaag, M McGee, J P McEvoy, O Freudenreich, W H Wilson, T B Coope. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. The American journal of psychiatry. vol 153. issue 12. 1997-01-08. PMID:8942454. |
response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. |
1997-01-08 |
2023-08-12 |
Not clear |
| R W Buchanan, B Kirkpatrick, N Bryant, P Ball, A Breie. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia. The American journal of psychiatry. vol 153. issue 12. 1997-01-08. PMID:8942462. |
fluoxetine augmentation of clozapine treatment in patients with schizophrenia. |
1997-01-08 |
2023-08-12 |
Not clear |
| D C Goff, G Tsai, D S Manoach, J Flood, D G Darby, J T Coyl. D-cycloserine added to clozapine for patients with schizophrenia. The American journal of psychiatry. vol 153. issue 12. 1997-01-08. PMID:8942463. |
d-cycloserine added to clozapine for patients with schizophrenia. |
1997-01-08 |
2023-08-12 |
Not clear |
| J A Lieberma. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. The Journal of clinical psychiatry. vol 57 Suppl 11. 1997-01-02. PMID:8941173. |
clozapine represented the first significant advance in the pharmacotherapy of schizophrenia since the introduction of conventional antipsychotic drugs in the 1950's. |
1997-01-02 |
2023-08-12 |
Not clear |
| J A Lieberma. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. The Journal of clinical psychiatry. vol 57 Suppl 11. 1997-01-02. PMID:8941173. |
despite its superior efficacy and potential to reduce substantially the morbidity of schizophrenia and improve the outcomes, of patients, clozapine has not been used on a widespread basis or as a first-line treatment due to its potential for agranulocytosis. |
1997-01-02 |
2023-08-12 |
Not clear |
| D D Mille. The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 8. issue 2. 1996-12-26. PMID:8807035. |
the clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia. |
1996-12-26 |
2023-08-12 |
Not clear |
| D D Mille. The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 8. issue 2. 1996-12-26. PMID:8807035. |
six recent studies have examined the utility of clozapine plasma concentrations in predicting response in treatment-refractory patients with schizophrenia. |
1996-12-26 |
2023-08-12 |
Not clear |
| D D Mille. The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 8. issue 2. 1996-12-26. PMID:8807035. |
thus, there is now compelling evidence that clozapine plasma concentrations may play an important role in maximizing the probability of clinical response to clozapine in treatment-refractory schizophrenia. |
1996-12-26 |
2023-08-12 |
Not clear |